TLDR

MARKET RECAP → The major indexes finished Wednesday slightly above the flatline as escalating tensions in the Middle East put pressure on the markets.

PRIVATE PAYROLLS BEAT EXPECTATIONS → 💼 Private payrolls jumped by 143,000 in September, beating forecasts and showing the labor market still has some fight left—just enough to keep the Fed on its toes.

ELI LILLY'S $4.5 BILLION BET→ 🏗️ Eli Lilly is betting big with a $4.5 billion research and manufacturing center, set to supercharge their drug pipeline and keep them at the cutting edge of pharma innovation.

Was this email forwarded to you? Sign up for free here.

MARKETS

Today’s S&P 500 Heatmap

Notable Earnings This Week

TODAY’S TOP NEWS

Private Payrolls Beat Expectations

💼 Private payrolls increased by 143,000 in September, surpassing the expected 128,000. This marked an improvement from August’s growth of 103,000, signaling resilience in the labor market despite broader economic uncertainties.

📊 ADP’s report highlighted better-than-expected job growth, driven by industries like healthcare and hospitality. However, the pace of hiring remained slower compared to earlier in the year, reflecting a more cautious approach by employers.

⚖️ The report added complexity to the Federal Reserve’s decision-making, as strong job growth could lead to inflationary pressures, while slower overall hiring trends suggested the economy was cooling.

TODAY’S TOP NEWS

Eli Lilly’s $4.5 Billion Bet

🏗️ Eli Lilly announced a $4.5 billion investment in a new research and manufacturing center, set to open in late 2027. This facility would focus on producing small molecules, biologics, and genetic medicines to fuel the company’s future drug pipeline.

💊 The center aims to accelerate the development of breakthrough therapies, positioning Eli Lilly at the forefront of cutting-edge treatments. The facility would play a crucial role in expanding their ability to innovate in areas like oncology and diabetes.

🚀 This bold move underscored Eli Lilly's commitment to growth, as the company seeks to ramp up production capacity and stay competitive in the evolving pharmaceutical landscape.

BULL VS. BEAR

NOTABLE POSTS

KEEP READING

Massive port strike could have ‘devastating consequences’ for consumers, expert says (CNBC)

Facebook owner Meta forms data-sharing pact with UK banks to counter scams (CNBC)

Microsoft’s new Windows 11 update comes with energy use and Wi-Fi enhancements (CNBC)

CVS Health to lay off nearly 3,000 workers in cost-cutting drive (CNN)

Verizon confirms service is back online after a major outage (CNN)

The Hidden Costs of Convenience (ML)

Bankruptcy vs. Debt Consolidation (ML)

Are You Paying Any Hidden Or Unnecessary Fees?(ML)

WHAT WE’RE WATCHING

OUR FAVORITE TOOLS & RESOURCES

• Earnings Hub — Earnings calendar

• Quiver Quantitative — Quiver allows retail investors to tap into the power of big data with insights into things like congressional trades as they are disclosed

• Perplexity — Perplexity AI is an AI-chatbot-powered research and conversational search engine

• The Market Ear — Live news, analysis and commentary on what moves markets and trading

• Coinmarketcap.com — Crypto market data

• Finviz — Financial visualizations

• Trading Economics — Economic calendar

• CME FedWatch Tool — Market-implied probabilities of future levels of interest rates 

• Dataroma — Track stock picks and portfolios of legendary value investors such as Warren Buffett

• ChatGPT — Large language model-based chatbot powered by generative AI

• Vimcal — Lightning-fast calendar and AI scheduling assistant

^{_{The Bull vs. Bear Merchandise Promotion is a limited time campaign that begins on December 1, 2023 at 12:00 AM ET and ends on the date that there are no more Rewards. This Promotion is available to any registered MoneyLion user who is a legal resident of the 50 United States or the District of Columbia and who has reached the age of majority in their state as of the beginning of the Promotional Period. See terms and conditions here.}}

<sup><sub>This advertising email was sent to you because you have a MoneyLion account. If you would like to unsubscribe, please do so using this link. We respect your right to privacy. Please do not reply to this email with sensitive information, such as an account number, Social Security number, date of birth, bank account information, PIN, password, or Online ID. The security and confidentiality of your personal information is important to us. If you have any questions or want to read more, please visit our Help Center.

MoneyLion and Pathward do not provide, nor do they guarantee, any third-party product, service, information, or recommendation. The third parties providing these products or services are solely responsible for them, as well as all other content on their websites. MoneyLion is not liable for any third party’s failure with regard to those advertised products, services, and benefits. These advertised products and services may not be FDIC insured or bank-guaranteed, and may be subject to a different privacy policy than MoneyLion’s. You should check individual offers, products, and services to become familiar with any applicable restrictions or conditions that may apply. MoneyLion may receive compensation from third parties for referring you to the third party, their products or to their website.

The influencer, creator and other content provided in the MoneyLion App (“Content”) is for informational and entertainment purposes only and should not be construed as legal, tax, investment, financial, or other advice. All Content is intended to be of a general nature, does not address the circumstances of any particular individual or entity, and may not constitute a comprehensive or complete statement of the matters discussed. MoneyLion is not a fiduciary by virtue of any person’s use of or reliance on the Content. You should consult an appropriate professional if you require any legal, tax, investment, financial or other advice. Terms and Conditions for our subscriber referral can be found here.</sub></sup>